Article Versions Notes

Tang L, Zhu M, Che X, Yang X, Xu Y, Ma Q, Zhang M, Ni Z, Shao X, Mou S. Astragaloside IV Targets Macrophages to Alleviate Renal Ischemia-Reperfusion Injury via the Crosstalk between Hif-1α and NF-κB (p65)/Smad7 Pathways. Journal of Personalized Medicine. 2023; 13(1):59. https://doi.org/10.3390/jpm13010059

Tang, Lumin, Minyan Zhu, Xiajing Che, Xiaoqian Yang, Yao Xu, Qing Ma, Ming Zhang, Zhaohui Ni, Xinghua Shao, and Shan Mou. 2023. "Astragaloside IV Targets Macrophages to Alleviate Renal Ischemia-Reperfusion Injury via the Crosstalk between Hif-1α and NF-κB (p65)/Smad7 Pathways" Journal of Personalized Medicine 13, no. 1: 59. https://doi.org/10.3390/jpm13010059

Tang, L., Zhu, M., Che, X., Yang, X., Xu, Y., Ma, Q., Zhang, M., Ni, Z., Shao, X., & Mou, S. (2023). Astragaloside IV Targets Macrophages to Alleviate Renal Ischemia-Reperfusion Injury via the Crosstalk between Hif-1α and NF-κB (p65)/Smad7 Pathways. Journal of Personalized Medicine, 13(1), 59. https://doi.org/10.3390/jpm13010059